Education
About Us
Working with TipRanks
Follow Us
Hua Medicine Ltd. (HK:2552)
:2552
Total Valuation
Hua Medicine has a market cap or net worth of $4.70B. The enterprise value is HK$1.98B.
Market Cap$4.70B
Enterprise ValueHK$1.98B
Share Statistics
Hua Medicine has 1,056,213,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,056,213,700
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Hua Medicine’s return on equity (ROE) is 1.85 and return on invested capital (ROIC) is -26.87%.
Return on Equity (ROE)1.85
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-26.87%
Return on Capital Employed (ROCE)-0.29
Revenue Per Employee1.52M
Profits Per Employee-1.49M
Employee Count168
Asset Turnover0.17
Inventory Turnover1.04
Valuation Ratios
The current PE Ratio of Hua Medicine is 4.1. Hua Medicine’s PEG ratio is -0.39.
PE Ratio4.1
PS Ratio5.26
PB Ratio-9.93
Price to Fair Value-9.93
Price to FCF-3.19
Price to Operating Cash Flow-15.98
PEG Ratio-0.39
Income Statement
In the last 12 months, Hua Medicine had revenue of 255.89M and earned -250.14M in profits. Earnings per share was -0.25.
Revenue255.89M
Gross Profit124.72M
Operating Income-352.64M
Pretax Income-250.14M
Net Income-250.14M
EBITDA-345.36M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -275.61M and capital expenditures 962.00K, giving a free cash flow of -274.64M billion.
Operating Cash Flow-275.61M
Free Cash Flow-274.64M
Free Cash Flow per Share-0.26
Dividends & Yields
Hua Medicine pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change250.72%
50-Day Moving Average3.85
200-Day Moving Average2.67
Relative Strength Index (RSI)67.51
Average Volume (3m)9.65M
Important Dates
Hua Medicine upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Hua Medicine as a current ratio of 4.05, with Debt / Equity ratio of 25.59%
Current Ratio4.05
Quick Ratio3.66
Debt to Market Cap0.18
Net Debt to EBITDA2.43
Interest Coverage Ratio-40.96
Taxes
In the past 12 months, Hua Medicine has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Hua Medicine EV to EBITDA ratio is -1.47, with an EV/FCF ratio of -1.20.
EV to Sales1.98
EV to EBITDA-1.47
EV to Free Cash Flow-1.20
EV to Operating Cash Flow-1.21
Balance Sheet
Hua Medicine has $1.02B in cash and marketable securities with $271.05M in debt, giving a net cash position of $751.74M billion.
Cash & Marketable Securities$1.02B
Total Debt$271.05M
Net Cash$751.74M
Net Cash Per Share$0.71
Tangible Book Value Per Share-$0.16
Margins
Gross margin is 52.55%, with operating margin of -137.81%, and net profit margin of -97.75%.
Gross Margin52.55%
Operating Margin-137.81%
Pretax Margin-97.75%
Net Profit Margin-97.75%
EBITDA Margin-134.96%
EBIT Margin-140.80%
Analyst Forecast
The average price target for Hua Medicine is $4.98, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$4.98
Price Target Upside2.92% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast238.71%
EPS Growth Forecast―